Optimizing the dasatinib dose regimen in chronic phase chronic myeloid leukemia: 100 mg once daily available for use
Ravi VijVolume:
6
Year:
2009
Language:
english
DOI:
10.1016/s1548-5315(11)70371-0
File:
PDF, 63 KB
english, 2009